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ABSTRACT
Background: Recent registry studies have demonstrated a higher prevalence of asthma among women with
polycystic ovary syndrome (PCOS). We aimed to assess the association and heritability of PCOS and
asthma in a Danish twin cohort.
Methods: Data for 32382 female twins from the Danish Twin Registry were included. Twins with PCOS
were identified by searching the Danish National Patient Registry for International Classification of
Diseases-10 code E28.2. Asthma was diagnosed by questionnaires.
Results: 103 (0.3%) women had a PCOS diagnosis. The risk of asthma was increased among women with
PCOS compared with women without (18% versus 9%, respectively; OR 2.11 (95% CI 1.13–3.96); p=0.02).
After adjustment for age, body mass index, alcohol consumption and smoking status, the risk of asthma
was still increased, but was no longer statistically significant (OR 1.54 (95% CI 0.75–3.17); p=0.24).
Variance components analysis showed that shared environmental factors explained 49% (95% CI 24–68%)
and unique environmental factors explained 51% (95% CI 32–76%) of the susceptibility to PCOS. For
asthma, 44% (95% CI 28–61%) of the variance was explained by genetic factors, whereas 25% (95% CI
11–38%) was ascribable to shared environmental factors and 31% (95% CI 26–36%) to unique
environmental factors.
Conclusion: The risk of asthma is twice as high among female twins with PCOS. The individual
susceptibility to PCOS is mainly due to environmental factors and not genetics.
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Introduction
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of fertile age,
affecting as many as 10% [1]. In addition, asthma is the most common chronic disease in industrialised
societies. Women in particular suffer from late-onset asthma and the prevalence of nonatopic asthma is
high among adult females [2]. Moreover, both diagnoses can have a massive impact on personal, social
and socioeconomic wellbeing, with a negative effect on quality of life [3, 4]. Despite the high incidence of
both asthma and PCOS, little is known about the association and heredity of the two conditions.
The Rotterdam 2003 consensus criteria, used to diagnose PCOS, were first defined almost two decades
ago [5]. According to the Rotterdam 2003 consensus, after the exclusion of related disorders, two of the
following three criteria must be fulfilled for the diagnosis for PCOS: oligo/anovulation, clinical and/or
biochemical hyperandrogenaemia, and presence of polycystic ovaries.
The risk of obesity (metabolic syndrome), cardiovascular disease and diabetes is also increased among
women with PCOS [6]. Higher risk of asthma and greater use of asthma and allergy medication have been
found among women with PCOS compared with women without PCOS [7, 8]. The pathogenesis of PCOS
has not yet been fully elucidated. However, genetics, systemic inflammation [9] and metabolic
dysregulation [10] play an important role in PCOS. A study conducted on a Dutch twin population
revealed that 66% of the variation in the susceptibility to PCOS could be explained by genetic factors,
whereas 5% was explained by common environmental factors and 29% by nonshared environmental
factors [11], illustrating the importance of a genetic predisposition in this disorder.
Asthma is characterised by respiratory symptoms along with hyperresponsiveness, inflammation and
reversible obstruction of the airways [12, 13]. As with PCOS, asthma is associated with impaired fertility,
probably due to inflammation and metabolic syndrome [14]. Twin studies investigating the heredity of
asthma have demonstrated a genetic impact on the risk of asthma development throughout life [15]. Twin
studies are a unique method for investigating the contribution of genetic and environmental factors to
disease risk in a population.
The aim of this study was to examine the prevalence and association of PCOS and asthma in a large
nationwide Danish twin population, and furthermore to estimate the genetic and environmental
contributions to PCOS and asthma using the classical twin method.
Methods
Design
In this study, data from the Danish Twin Registry and the Danish National Patient Registry were
cross-referenced.
The Danish Twin Registry
The Danish Twin Registry contains data for twins born between 1931 and 2000 in Denmark. Throughout
these years three twin cohorts have been included in the registry by completing multidisciplinary
questionnaires on lifestyle, health and socioeconomic status. The questionnaires were named OMNIBUS
1994 (twins born 1953–1982; response rate 86%), OMNIBUS 2002 (twins born 1931–1982; response rate
75%) and BTU 2003 (twins born 1983–2000; response rate 68%).
In total, 32382 individual female twins born between 1931 and 2000 were included in our study
population (figure 1). Data on asthma diagnosis, smoking and alcohol consumption, body mass index
(BMI), and zygosity were included from the OMNIBUS 1994, OMNIBUS 2002 and BTU 2003
questionnaires [16].
Questionnaires
Asthma
OMNIBUS 1994 identified asthma by the following question: “Have you ever had asthma?” with the
response options “yes” or “no”. OMNIBUS 2002 identified asthma by the following question: “Do you
have, or have you ever had asthma?” with the response options “yes, I have it now”, “yes, I have had it” or
“no”. BTU 2003 identified asthma by the following questions, answered by the parents or by the twin
individual, respectively: “Has your child ever had asthma?” and “Have you ever had asthma?” with the
response options of leaving a check box marked or unmarked. In all three surveys, asthma was defined by
a positive response to the question(s).
The majority of the twins born during 1953–1982 participated in both OMNIBUS 1994 and 2002. If the
diagnosis of asthma was present in at least one of the questionnaires, the twin was categorised as having
asthma.
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Alcohol consumption
In OMNIBUS 1994 and 2002, alcohol consumption was based on the following questions: “Do you drink
alcohol: yes/no – if “yes”, how many units of alcohol (beer, hard liquor, wine and liquor) do you drink
each week?”. Alcohol consumption was not addressed in BTU 2003.
Smoking status
In OMNIBUS 1994 and 2002, smoking status was based on the following categories: never-, ex- or current
smoker. Smoking status was not addressed in BTU 2003.
Body mass index
BMI was calculated as for all subjects ⩾18 years of age based on self-reported height and weight. For
individuals <18 years of age the z-score was calculated using the height, weight and age. BMI was divided
into four categories: underweight (BMI <18.5 kg·m−2), normal weight (BMI 18.5–24.9 kg·m−2), overweight
(BMI 25.0–29.9 kg·m−2) and obese (BMI ⩾30.0 kg·m−2).
Zygosity
The zygosity of the twins was determined by four questions of similarity and mistaken identity, which
assign zygosity correctly in >96% of cases compared with genetic marker information [17].
The twin method
The principle of the classical twin method is that monozygotic (MZ) twins share all of their genetic
makeup, whereas dizygotic (DZ) twins only share half their genes [18]. If MZ twins are more alike for a
disease compared with DZ twins, genetic factors can be assumed to contribute to the disease risk.
Furthermore, the variation of the phenotypic trait can be divided into an environmental component
(shared (C) or unique (E)) and a genetic (A) component according to genetic theory: the ACE model.
This model estimates the proportion of the variance explained by genetic factors and the proportion
explained by environmental (shared or unique) factors [19].
The Danish National Patient Registry
The Danish National Patient Registry contains all diagnosed diseases at public hospitals in Denmark since
1977. The register covers both inpatient and outpatient contacts. Between 1977 and 1993 the database used
International Classification of Diseases (ICD)-8 codes; from 1994 onwards the database used ICD-10
codes. From 1977 only inpatient contacts were registered, whereas from 1995 the Danish National Patient
Registry recorded both inpatient and outpatient contacts [20].
PCOS diagnosis
The ICD-10 code E28.2 (PCOS) at hospital discharge was used to identify women with PCOS in the
Danish National Patient Registry. We used PCOS diagnosis at discharge to ensure that the diagnosis was
confirmed, as a diagnosis at the point of admission is often a suspected or working diagnosis. All data
were extracted in October 2014.
All twins in the Danish Twin Registry who
participated in the questionnaires
n=54 726 individuals
Female individuals from
OMNIBUS 2002
n=19 037
Female individuals from
BTU 2003
n=9870
Female individuals from
OMNIBUS 1994
n=15 250
Female twins included in
the registry study
n=32 382
Unique female twin
individuals
n=22 512
FIGURE 1 Flowchart of study inclusion.
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Ethics
The Regional Scientific Ethics Committee approved the questionnaire study and the cross-linking of data
was approved by the Danish Data Protection Agency (approval 2012-58-0004).
Statistical analysis
Chi-squared and t-tests were used to compare baseline characteristics in the PCOS and non-PCOS groups.
The risk of asthma in patients with PCOS was estimated using multiple logistic regression with age,
smoking, alcohol consumption and BMI as covariates. SPSS version 23 (IBM, Armonk, NY, USA) was
used for these analyses.
The probandwise concordance (CPr) expresses the probability of one twin being affected given the co-twin
is affected. CPr is calculated as 2×number of concordant pairs/(2×number of concordant pairs+number of
discordant pairs). The proportion of the variation in PCOS susceptibility explained by genetic and
environmental factors was estimated from the number of unaffected twins, discordant and concordant
pairs included. These estimations were computed using the statistical software Mx according to the
methods described by NEALE and CARDON [21].
Results
Of the 32382 female twins included in the study, 103 (0.3%) had the ICD-10 code E28.2 for PCOS. The
PCOS group was significantly younger than the non-PCOS group (mean±SD 22±8.2 versus 31±18.9 years;
p<0.001) and a significantly larger proportion were never-smokers (63% versus 45%; p=0.02). The
proportion of obese individuals in the PCOS group was also significantly higher (16% versus 6%; p<0.001).
Alcohol consumption was similar in the two groups (table 1).
The prevalence of asthma was significantly higher in the PCOS group (18% versus 9%; OR 2.11 (95% CI
1.13–3.96); p=0.02). After adjustment for age, BMI, alcohol consumption and smoking status, the risk of
asthma was still increased, but was no longer statistically significant (OR 1.54 (95% CI 0.75–3.17); p=0.24)
(table 1).
Two of the MZ twin pairs and one DZ twin pair were concordant for PCOS, whereas 33 of the MZ twin
pairs and 30 of the DZ twin pairs were discordant for PCOS. The CPr of PCOS was 0.108 among MZ
twins and 0.063 among DZ twins (p=0.628 for comparison between MZ and DZ twins). The CPr of
asthma was significantly higher among MZ than among DZ twins (0.45 versus 0.30; p<0.001) (table 2).
Variance components analysis according to the full ACE model showed that 5% (95% CI 0–72%) of the
variance in the susceptibility to PCOS was explained by genetic factors, whereas shared environmental
TABLE 1 Descriptive statistics among female twins with and without polycystic ovary syndrome (PCOS)
Non-PCOS PCOS Crude OR (95% CI) p-value Adjusted OR (95% CI)# p-value
Subjects 32279 103
Age¶,+ years 31±18.9 22±8.2 0.92 (0.88–0.93) <0.001 0.99 (0.99–0.99) 0.004
BMI kg·m−2 (n=29195)
<18.5 (underweight) 1269 (4) 3 (3) 0.38 (0.05–2.80) 0.35 1.13 (0.89–1.44) 0.33
18.5–24.9 (normal weight) 21019 (72) 66 (68) Reference Reference
25.0–29.9 (overweight) 5151 (18) 13 (13) 0.98 (0.50–1.92) 0.96 1.35 (1.19–1.54) <0.001
⩾30.0 (obese) 1659 (6) 15 (16) 3.58 (1.94–6.66) <0.001 1.92 (1.61–2.28) <0.001
Alcohol units·week−1 (n=20053)
Never 3678 (18) 11 (18) Reference Reference
1–6 11427 (57) 39 (63) 1.14 (0.58–2.23) 0.70 0.88 (0.77–1.00) 0.06
7–13 3392 (17) 12 (19) 1.18 (0.52–2.68) 0.69 0.89 (0.75–1.05) 0.16
14–20 1101 (6) 0 (0) 0.00 0.99 0.92 (0.72–1.17) 0.45
⩾21 393 (2) 0 (0) 0.00 0.99 1.00 (0.69–1.44) 0.99
Smoking status (n=21839)
Never-smoker 9883 (45) 42 (63) Reference Reference
Ex-smoker 4267 (20) 8 (12) 0.44 (0.21–0.94) 0.04 1.38 (1.21–1.58) <0.001
Current smoker 7622 (35) 17 (25) 0.53 (0.30–0.92) 0.03 1.19 (1.06.–1.33) 0.004
Asthma 2959 (9) 18 (18) 2.11 (1.13–3.96) 0.02 1.56 (0.76–3.19) 0.23
Data are presented as n, mean±SD or n (%), unless otherwise stated. BMI: body mass index. #: adjusted for age, BMI, alcohol and smoking;
¶: age when filling in the questionnaire; +: OR for age measured per year. Within black box: univariate logistic regression; outside black box:
multivariate logistic regression. p<0.05 considered significant.
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factors and unique environmental factors explained 45% (95% CI 0–68%) and 50% (95% CI 27–76%) of
the variance in susceptibility, respectively. The most parsimonious model was the CE model (p=0.923 for
difference between the ACE and the CE model), in which shared environmental factors explained 49%
(95% CI 24–68%) and unique environmental factors explained 51% (95% CI 32–76%) of the variance in
the susceptibility to PCOS.
According to the best-fitting model for asthma, 44% (95% CI 28–61%) of the variance in the susceptibility
to asthma was explained by genetic factors, whereas 25% (95% CI 11–38%) was ascribable to shared
environmental factors and 31% (95% CI 26–36%) to unique environmental factors.
Discussion
We demonstrated an increased risk of having asthma and PCOS simultaneously. After adjustment for
confounders such as age, BMI, smoking and alcohol consumption, the association was statistically
insignificant, but still demonstrating an increased OR of 1.54; possibly an association is present but our
study lacks power. Furthermore, twin variance components analysis indicated that the individual
susceptibility to PCOS was best explained by environmental factors alone. In addition, we confirmed
previous findings of a strong genetic component in the susceptibility to asthma.
Interestingly, another large Danish register-based study (of non-twin women) also demonstrated a
significantly higher prevalence of asthma among women with PCOS compared with women without
PCOS (3% versus 2.2%) [7]. This finding was supported by two large Australian register-based studies. In
a study by HART and DOCHERTY [22], a significantly higher prevalence of asthma among women with PCOS
was found (10.6% versus 4.5%; hazard ratio 2.51) compared with women without PCOS. These findings
show an even higher prevalence of asthma and PCOS in Australian women than in the Danish cohort. A
further study using the same cohort demonstrated that pregnant women with PCOS have a significantly
higher prevalence of asthma compared with pregnant women without PCOS (13.6% versus 9.9%) [23].
Pregnancy in general leads to a higher prevalence of asthma symptoms and asthma exacerbations with
emergency visits [24]. One could argue that women with PCOS have an even higher risk of asthma when
being pregnant compared with pregnant women without PCOS based on the Australian study.
The possible association of PCOS and asthma could be explained by several factors. First, smoking is
known to increase the risk of asthma and the risk of asthma exacerbations [25]. Interestingly, we found a
higher prevalence of never-smokers among women with PCOS compared with women without PCOS. As
a higher prevalence of asthma is seen among women with PCOS in spite of less smoking, PCOS seems to
be a risk factor for asthma independently of smoking status.
The metabolic syndrome and obesity play an important role for both PCOS and asthma, affecting as many
as half of patients with PCOS [26] and 11% of patients with asthma [27]. Weight loss improves symptoms
for both groups of patients [28–31]. Thus, being overweight or gaining weight could lead to, or at least
affect, the risk of developing asthma [32]. This was reflected in the higher prevalence of obesity and
asthma seen among the women with PCOS in our study.
In a recent Australian study, the association of PCOS and asthma remained significant after adjustment for
BMI and smoking status, and participants suffering from both diseases were more obese than women with
PCOS alone [8]. This illustrates how the metabolic syndrome might increase the risk for the development
of asthma among women with PCOS. As the environmental contribution to the development of PCOS, as
TABLE 2 Occurrence and resemblance between female twins for polycystic ovary syndrome
(PCOS) and asthma
Zygosity Pairs Discordant pairs Concordant pairs CPr p-value
PCOS 0.628
MZ 3625 33 2 0.108
DZ 5196 30 1 0.063
Total 8821 63 3
Asthma <0.001
MZ 3570 358 147 0.45
DZ 5096 664 140 0.30
Total 8666 1022 287
Data are presented as n, unless otherwise stated. CPr: probandwise concordance; MZ: monozygotic; DZ:
dizygotic. p<0.05 considered significant.
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shown in this study, is central, weight control is essential in the prevention of PCOS. However, prospective
studies are needed to elucidate the order of events and determine causality.
The possible association of PCOS and asthma could also be due to a common systemic inflammatory
pathway. Systemic inflammation in PCOS is characterised by raised levels of C-reactive protein,
interleukin-6, tumour necrosis factor, neutrophils and lymphocytes [33, 34]. However, a more specific
inflammatory pathway in PCOS has yet to be defined. Conversely, the pathway of systemic inflammation
in asthma has been thoroughly investigated, especially the T-helper type 2 (Th2) pathway [35, 36]. Less
eosinophilia is seen among asthmatic obese women, indicating a predominantly non-Th2 type of
asthma [37]. The idea of a pathophysiological link between PCOS and asthma through the degree of
systemic inflammation and metabolic factors is plausible. Systemic inflammation is known to increase with
being overweight [38].
Our twin analysis indicated that genetic factors did not contribute to the risk of PCOS, but rather that
common environmental factors and unique environmental factors explained the variation in disease risk.
These findings are in contrast to the findings of a Dutch twin study [11]. The difference in variance
components could be explained by the different diagnostic criteria used in the Dutch study and in our
study. In the Dutch study, less than nine menstruations per year and hirsutism or acne were used to define
the PCOS diagnosis, whereas we used the ICD code for PCOS, ensuring the most exact patient selection.
Given that the environmental contribution to PCOS may have the greatest impact on the disease, this
must be incorporated in future research, patient information and disease control to ensure the best
possible treatment.
A limitation of our twin study is the low prevalence of PCOS, at 0.3%, which is lower than the 6–10%
observed in the general population [1]. The underestimation of PCOS may be due to a conservative
approach and the use of hospital registry information or the fact that many women with PCOS remain
undiagnosed for years [39, 40]. Lastly, recall bias regarding asthma, height and weight is a possible
limitation of our study as the twin registry is based on self-reported questionnaires. Nevertheless, 89% of
the twins diagnosed through the questionnaires with asthma were subsequently diagnosed with asthma at
a clinical examination compared with only 12% of those with no asthma diagnosis according to the
questionnaires [41].
In conclusion, the risk of asthma is twice as high among female twins with PCOS compared with those
without PCOS. This study was unable to support the findings of earlier studies that there is a significant
genetic susceptibility to PCOS. For asthma, in contrast, genetic factors were a major contributor to the risk
of disease. Future clinical and registry studies of the association of PCOS and asthma are needed.
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